Navigation Links
Blackstone Sells Gerresheimer Stake
Date:4/16/2008

DUSSELDORF, Germany, April 16 /PRNewswire-FirstCall/ -- The Blackstone Group has today informed us that it has decided to sell its close to 25% stake in Gerresheimer AG, held by BCP Murano II S.a.r.l. with immediate effect. In the course of the transaction, led by Credit Suisse, 7.8 million shares will be sold to a variety of institutional investors. Blackstone has thus decided to exit its Gerresheimer investment after Gerresheimer's IPO in June 2007. Dr. Axel Herberg, CEO of Gerresheimer AG: "Blackstone made a successful IPO possible and afforded us enormous growth opportunities. With this exit, our free float rises substantially, making our shares even more attractive to the investment community."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 41 production sites in Europe, America and Asia and employs approximately 10,800 employees worldwide.

Contact Press

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

E-Mail: b.lingenberg@gerresheimer.com

Contact Investor Relations

Anke Linnartz

Director Corporate Investor Relations

Telephone: +49-211-6181-314

Telefax: +49-211-6181-121

E-Mail: a.linnartz@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Isolagen, Inc. Sells Switzerland Facility
2. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
3. Medifast Franchise Systems Sells First Territory in Baltimore
4. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
5. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
6. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
7. TeamStaff Sells Per Diem Business Unit
8. Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition
9. Informed Medical Communications Sells Consumer Internet Division to Revolution Health
10. Dragon Sells EPO Business; Focus on Antibiotic Core Business
11. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology: